Rahaf Omaish

Researcher

UAMS

Unknown Researcher

1 h-index 8 pubs 2 cited

Research Areas

Biomedical Subjects

Links

ORCID

OverviewAI-generated summary

Rahaf Omaish's research focuses on clinical aspects of various medical conditions, with recent publications addressing diagnostic challenges and treatment potentials. Her work includes investigating post-transplant lymphoproliferative disorder, particularly in cases with negative needle biopsies, and exploring the potential of triple therapy for diabetic kidney disease. Omaish has also studied acute kidney injury in patients receiving chimeric antigen receptor T cells, identifying risk factors and characteristics, and examining hypophosphatemia as a marker for immune effector cell-associated neurotoxicity syndrome in similar patient populations. Other research areas include iptacopan treatment for recurrent dense deposit disease after kidney transplant and the predictive value of MRI lesion burden in smoldering multiple myeloma. Additionally, her publications cover B-cell maturation antigen immunohistochemistry staining in multiple myeloma patients with prior BCMA-based therapy use.

Metrics

h-index: 1
Publications: 8
Citations: 2

Selected Publications

Acute Kidney Injury in Recipients of Chimeric Antigen Receptor T-Cell Therapy: Clinical Characteristics and Impact on Mortality (2026)

Transplantation and Cellular Therapy DOI OpenAlex
Potential of Triple Therapy in Diabetic Kidney Disease (2025)

Journal of the American Society of Nephrology 1 citation DOI OpenAlex
AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics (2025)

Journal of the American Society of Nephrology DOI OpenAlex
Hypophosphatemia as a Marker for Immune Effector Cell-Associated Neurotoxicity Syndrome in Chimeric Antigen Receptor T Cell Recipients (2025)

Journal of the American Society of Nephrology DOI OpenAlex
Post-Transplant Lymphoproliferative Disorder: A Diagnostic Challenge Following Negative Needle Biopsy (2025)

Journal of the American Society of Nephrology 1 citation DOI OpenAlex
Iptacopan treatment for recurrent dense deposit disease after kidney transplant: A case report (2025)

SAGE Open Medical Case Reports DOI OpenAlex
MRI lesion burden as a predictor of progression and survival in smoldering multiple myeloma. (2025)

Journal of Clinical Oncology DOI OpenAlex
B-cell maturation antigen (BCMA) immunohistochemistry (IHC) staining in multiple myeloma (MM) patients with prior use of BCMA-based therapies. (2025)

Journal of Clinical Oncology DOI OpenAlex